Nutrition education groups for treating type 2 diabetes
Official title: Effect of Nutritional Education Groups Added in the Usual Care of Outpatients with Type 2 Diabetes: a Randomized Clinical Trial
Run by Hospital de Clinicas de Porto Alegre · NCT05598203 · Data updated 2026-11-12
This study is testing whether adding nutrition education groups to regular treatment can help people with type 2 diabetes manage their blood sugar better and improve their overall health.
Quick facts
| Study type | Interventional |
|---|---|
| Sex | All |
| Enrollment | 252 (estimated) |
| Sponsor | Hospital de Clinicas de Porto Alegre Academic / other |
| Locations | 2 sites (Porto Alegre, Rio Grande do Sul and 1 other locations) |
| Status | Recruiting |
| Started | September 6, 2022 |
| Main results expected | March 30, 2025 |
| Study ends | October 30, 2025 |
| Registry record updated | March 18, 2025 |
| Trial ID | NCT05598203 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adult patients diagnosed with type 2 diabetes mellitus who are seeking to improve their health through lifestyle changes.
✕Probably not a fit
Patients with other types of diabetes, severe comorbidities, or those who do not meet the inclusion criteria may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study investigates the impact of integrating nutrition education groups into the standard treatment for patients with type 2 diabetes. It aims to enhance glycemic control, reduce complications, and improve overall quality of life through a randomized clinical trial. Participants will receive either the usual care or the additional intervention of nutrition education in group settings. The outcomes measured will include glycemic control, lipid profiles, body mass, blood pressure, and adherence to dietary recommendations.
Why it matters
Potential benefit: If successful, this approach could lead to improved management of type 2 diabetes and better health outcomes for patients.
How similar studies have gone: Previous studies have shown that lifestyle interventions, including nutritional education, can significantly improve diabetes management, suggesting this approach may be effective.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: \- Adult patients with a previous diagnosis of type 2 diabetes mellitus Exclusion Criteria: * Patients with other types of diabetes * With HbA1C within the therapeutic target or with values greater than 12% * Severe neuropathy * Chronic kidney disease \[glomerular filtration rate \<30mL/min/1.73m²\] * Life expectancy \<6 months * Chemical dependence/alcoholism or use of antipsychotics * Autoimmune disease or chronic steroid use * Gastroparesis * Pregnant or lactating women * Patients who have had an Episode of Acute Coronary Syndrome (ACS) in the last 60 days * Wheelchair users * Cognitive, neurological or psychiatric condition
Where it's running
-
Hospital de Clinicas de Porto Alegre
Porto Alegre, Rio Grande do Sul, Brazil Recruiting -
Universidade Federal do Rio Grande do Sul
Porto Alegre, Rio Grande do Sul, Brazil Recruiting
Study contacts
- Principal investigator: Jussara C De Almeida, PhD — Federal University of Rio Grande do Sul
- Study coordinator: Jussara C De Almeida, PhD
- Email: jcalmeida@hcpa.edu.br
- Phone: +555133598410
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Proliverenol for liver fat and insulin resistance in type 2 diabetes
This study tests whether adding Proliverenol to standard diabetes care can improve liver fat and blood sugar control in adults with type 2 diabetes.
-
Whole-Body Vibration Training in Women With Obesity With and Without Type 2 Diabetes
This study tests whether eight weeks of supervised whole-body vibration training changes ankle muscle activity and walking performance in women with obesity, comparing those with and without type 2 diabetes.
-
Safety test of NNC9836-0001 in adults with overweight/obesity or type 2 diabetes
This study tests whether the new medicine NNC9836-0001 is safe and tolerable in adults who are overweight or have type 2 diabetes, compared to placebo.
-
RIGHTEST iFree 2 CGM in Pregnant Women With Diabetes
This study tests the accuracy and safety of the RIGHTEST iFree 2 continuous glucose monitor in pregnant adults with type 1, type 2, or gestational diabetes.
-
EloraTZP for weight loss in adults with overweight/obesity and type 2 diabetes
This trial tests whether a coformulation of eloralintide and tirzepatide helps people with obesity or overweight and type 2 diabetes lose weight compared with tirzepatide alone.
-
Maridebart cafraglutide vs. semaglutide for type 2 diabetes on metformin
This trial tests whether maridebart cafraglutlide is as good as semaglutide at improving blood sugar in adults with type 2 diabetes who take metformin (with or without an SGLT-2 inhibitor).
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.